C反応性タンパク(CRP)検査市場レポート：2030年までの動向、予測、競合分析

C反応性タンパク検査の動向と予測

世界のC反応性タンパク検査市場は、2024年から2030年までのCAGRが2.8%で、2030年までに推定61億米ドルに達すると予測されます。この市場の主な促進要因は、心血管疾患の頻度の上昇、ポイントオブケア・スクリーニングの導入とC反応性タンパク（CRP）検査のための最先端手法の開発を目的とした政府プログラムの拡大、および心血管疾患、関節リウマチ、炎症性疾患などの慢性疾患の割合の増加です。世界のC反応性タンパク検査市場の将来は、クリニック、病院、検査室、介護付きヘルスケア施設、家庭市場などでの機会により有望視されています。

C反応性タンパク検査市場の洞察

Lucintelは、心血管疾患の頻度増加により、予測期間中も心血管疾患が最大セグメントであり続けると予測しています。

北米は、心血管疾患罹患率の上昇、定期的な製品導入の流れ、確立された業界競合企業の存在により、予測期間中も最大地域であり続けるでしょう。

よくある質問

Q1.市場規模は？

A1.世界のC反応性タンパク検査市場は、2030年までに推定61億米ドルに達すると予想されています。

Q2.市場の成長予測は？

A2.世界のC反応性タンパク検査市場は、2024年から2030年にかけてCAGR 2.8％で成長すると予想されます。

Q3.市場の成長に影響を与える主な促進要因は？

A3.この市場の主な促進要因は、心血管疾患の頻度の上昇、ポイントオブケア・スクリーニングの導入とC反応性タンパク（CRP）検査の最先端手法の開発を目的とした政府プログラムの拡大、および心血管疾患、関節リウマチ、炎症性疾患などの慢性疾患の罹患率の増加です。

Q4.市場の主要セグメントは？

A4.世界のC反応性タンパク検査市場の将来は、クリニック、病院、検査室、介護付きヘルスケア施設、家庭市場において有望です。

Q5.市場の主要企業は？

A5.主要なC反応性タンパク検査企業は以下の通りです。

• Thermo Fisher Scientific
• F. Hoffmann-La Roche
• Danaher
• Quest Diagnostics
• Siemens Healthineers
• Abbott
• Merck
• Zoetis
• Ortho Clinical Diagnostics
• Getein Biotech

Q6.今後、最大となる市場セグメントは？

A6.Lucintelは、心血管疾患の頻度の増加により、予測期間中、心血管疾患が最大のセグメントであり続けると予測しています。

Q7.市場において、今後5年間に最大になると予想される地域は？

A7.北米は、心血管疾患罹患率の上昇、定期的な製品導入の流れ、確立された業界競合企業の存在により、予測期間中も最大地域であり続ける。

Q8.レポートのカスタマイズは可能？

A8.はい、Lucintelは追加費用なしで10%のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界のC反応性タンパク検査市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界のC反応性タンパク検査市場動向（2018～2023年）と予測（2024～2030年）
• 測定法別の世界のC反応性タンパク検査市場
  • 免疫比濁測定法
  • エリサ法
  • 化学発光免疫測定法
  • その他
• 検出範囲別の世界のC反応性タンパク検査市場
  • hsCRP（高感度CRP）
  • 従来のCRP
  • cCRP（CardioPhase）
• 疾患別の世界のC反応性タンパク検査市場
  • 心血管疾患
  • がん
  • 関節リウマチ
  • 炎症性腸疾患
  • 子宮内膜症
  • 狼瘡
  • その他
• 最終用途別の世界のC反応性タンパク検査市場
  • 診療所
  • 病院
  • 研究室
  • 生活支援ヘルスケア施設
  • 在宅
  • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

• 地域別の世界のC反応性タンパク検査市場
• 北米のC反応性タンパク検査市場
• 欧州のC反応性タンパク検査市場
• アジア太平洋のC反応性タンパク検査市場
• その他地域のC反応性タンパク検査市場

第5章 競合の分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

• 成長機会分析
  • アッセイタイプ別の世界のC反応性タンパク検査市場の成長機会
  • 検出範囲別の世界のC反応性タンパク検査市場の成長機会
  • 疾患別の世界のC反応性タンパク検査市場の成長機会
  • 最終用途別の世界のC反応性タンパク検査市場の成長機会
  • 地域別の世界のC反応性タンパク検査市場の成長機会
• 世界のC反応性タンパク検査市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界のC反応性タンパク検査市場の能力拡大
  • 世界のC反応性タンパク検査市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• Thermo Fisher Scientific
• F. Hoffmann-La Roche
• Danaher
• Quest Diagnostics
• Siemens Healthineers
• Abbott
• Merck
• Zoetis
• Ortho Clinical Diagnostics
• Getein Biotech

C-Reactive Protein Testing Trends and Forecast

The future of the global C-reactive protein testing market looks promising with opportunities in the clinic, hospital, laboratories, assisted living healthcare facilities, and home markets. The global C-reactive protein testing market is expected to reach an estimated $6.1 billion by 2030 with a CAGR of 2.8% from 2024 to 2030. The major drivers for this market are rising frequency of cardiovascular disorders, expanding government programs to introduce point-of-care screening and create cutting-edge methods for C-reactive protein (CRP) testing, as well as, increasing rates of chronic illnesses such cardiovascular disease, rheumatoid arthritis, and inflammatory disorders.

A more than 150-page report is developed to help in your business decisions.

C-Reactive Protein Testing by Segment

The study includes a forecast for the global C-reactive protein testing by assay type, detection range, disease, end use, and region.

C-Reactive Protein Testing Market by Assay Type [Shipment Analysis by Value from 2018 to 2030]:

• Immunoturbidimetric Assay
• ELISA
• Chemiluminescence Immunoassay
• Others

C-Reactive Protein Testing Market by Detection Range [Shipment Analysis by Value from 2018 to 2030]:

• hs-CRP
• Conventional CRP
• cCRP

C-Reactive Protein Testing Market by Disease [Shipment Analysis by Value from 2018 to 2030]:

• Cardiovascular Diseases
• Cancer
• Rheumatoid Arthritis
• Inflammatory Bowel Disease
• Endometriosis
• Lupus
• Others

C-Reactive Protein Testing Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Clinics
• Hospitals
• Laboratories
• Assisted Living Healthcare Facilities
• Home
• Others

C-Reactive Protein Testing Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of C-Reactive Protein Testing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies C-reactive protein testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the C-reactive protein testing companies profiled in this report include-

• Thermo Fisher Scientific
• F. Hoffmann-La Roche
• Danaher
• Quest Diagnostics
• Siemens Healthineers
• Abbott
• Merck
• Zoetis
• Ortho Clinical Diagnostics
• Getein Biotech

C-Reactive Protein Testing Market Insights

Lucintel forecasts that cardiovascular diseases will remain the largest segment over the forecast period due to the rise in the frequency of cardiovascular disorders.

North America will remain the largest region over the forecast period due to rising cardiovascular disease incidence, a regular stream of product introductions, and the existence of established industry competitors.

Features of the Global C-Reactive Protein Testing Market

Market Size Estimates: C-reactive protein testing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: C-reactive protein testing market size by various segments, such as by assay type, detection range, disease, end use, and region in terms of value ($B).

Regional Analysis: C-reactive protein testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different assay type, detection range, disease, end use, and regions for the C-reactive protein testing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the C-reactive protein testing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the C-reactive protein testing market size?

Answer: The global C-reactive protein testing market is expected to reach an estimated $6.1 billion by 2030.

Q2. What is the growth forecast for C-reactive protein testing market?

Answer: The global C-reactive protein testing market is expected to grow with a CAGR of 2.8% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the C-reactive protein testing market?

Answer: The major drivers for this market are rising frequency of cardiovascular disorders, expanding government programs to introduce point-of-care screening and create cutting-edge methods for C-reactive protein (CRP) testing, as well as, increasing rates of chronic illnesses such cardiovascular disease, rheumatoid arthritis, and inflammatory disorders.

Q4. What are the major segments for C-reactive protein testing market?

Answer: The future of the global C-reactive protein testing market looks promising with opportunities in the clinic, hospital, laboratories, assisted living healthcare facilities, and home markets.

Q5. Who are the key C-reactive protein testing market companies?

Answer: Some of the key C-reactive protein testing companies are as follows.

• Thermo Fisher Scientific
• F. Hoffmann-La Roche
• Danaher
• Quest Diagnostics
• Siemens Healthineers
• Abbott
• Merck
• Zoetis
• Ortho Clinical Diagnostics
• Getein Biotech

Q6. Which C-reactive protein testing market segment will be the largest in future?

Answer: Lucintel forecasts that cardiovascular diseases will remain the largest segment over the forecast period due to the rise in the frequency of cardiovascular disorders.

Q7. In C-reactive protein testing market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to rising cardiovascular disease incidence, a regular stream of product introductions, and the existence of established industry competitors.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the C-reactive protein testing market by assay type (immunoturbidimetric assay, elisa, chemiluminescence immunoassay, and others), detection range (hs-CRP, conventional CRP, and cCRP), disease (cardiovascular diseases, cancer, rheumatoid arthritis, inflammatory bowel disease, endometriosis, lupus, and others), end use (clinics, hospitals, laboratories, assisted living healthcare facilities, home, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global C-Reactive Protein Testing Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global C-Reactive Protein Testing Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global C-Reactive Protein Testing Market by Assay Type
  • 3.3.1: Immunoturbidimetric Assay
  • 3.3.2: ELISA
  • 3.3.3: Chemiluminescence Immunoassay
  • 3.3.4: Others
• 3.4: Global C-Reactive Protein Testing Market by Detection Range
  • 3.4.1: hs-CRP
  • 3.4.2: Conventional CRP
  • 3.4.3: cCRP
• 3.5: Global C-Reactive Protein Testing Market by Disease
  • 3.5.1: Cardiovascular Diseases
  • 3.5.2: Cancer
  • 3.5.3: Rheumatoid Arthritis
  • 3.5.4: Inflammatory Bowel Disease
  • 3.5.5: Endometriosis
  • 3.5.6: Lupus
  • 3.5.7: Others
• 3.6: Global C-Reactive Protein Testing Market by End Use
  • 3.6.1: Clinics
  • 3.6.2: Hospitals
  • 3.6.3: Laboratories
  • 3.6.4: Assisted Living Healthcare Facilities
  • 3.6.5: Home
  • 3.6.6: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global C-Reactive Protein Testing Market by Region
• 4.2: North American C-Reactive Protein Testing Market
  • 4.2.1: North American C-Reactive Protein Testing Market by Disease: Cardiovascular Diseases, Cancer, Rheumatoid Arthritis, Inflammatory Bowel Disease, Endometriosis, Lupus, and Others
  • 4.2.2: North American C-Reactive Protein Testing Market by End Use: Clinics, Hospitals, Laboratories, Assisted Living Healthcare Facilities, Home, and Others
• 4.3: European C-Reactive Protein Testing Market
  • 4.3.1: European C-Reactive Protein Testing Market by Disease: Cardiovascular Diseases, Cancer, Rheumatoid Arthritis, Inflammatory Bowel Disease, Endometriosis, Lupus, and Others
  • 4.3.2: European C-Reactive Protein Testing Market by End Use: Clinics, Hospitals, Laboratories, Assisted Living Healthcare Facilities, Home, and Others
• 4.4: APAC C-Reactive Protein Testing Market
  • 4.4.1: APAC C-Reactive Protein Testing Market by Disease: Cardiovascular Diseases, Cancer, Rheumatoid Arthritis, Inflammatory Bowel Disease, Endometriosis, Lupus, and Others
  • 4.4.2: APAC C-Reactive Protein Testing Market by End Use: Clinics, Hospitals, Laboratories, Assisted Living Healthcare Facilities, Home, and Others
• 4.5: ROW C-Reactive Protein Testing Market
  • 4.5.1: ROW C-Reactive Protein Testing Market by Disease: Cardiovascular Diseases, Cancer, Rheumatoid Arthritis, Inflammatory Bowel Disease, Endometriosis, Lupus, and Others
  • 4.5.2: ROW C-Reactive Protein Testing Market by End Use: Clinics, Hospitals, Laboratories, Assisted Living Healthcare Facilities, Home, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global C-Reactive Protein Testing Market by Assay Type
  • 6.1.2: Growth Opportunities for the Global C-Reactive Protein Testing Market by Detection Range
  • 6.1.3: Growth Opportunities for the Global C-Reactive Protein Testing Market by Disease
  • 6.1.4: Growth Opportunities for the Global C-Reactive Protein Testing Market by End Use
  • 6.1.5: Growth Opportunities for the Global C-Reactive Protein Testing Market by Region
• 6.2: Emerging Trends in the Global C-Reactive Protein Testing Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global C-Reactive Protein Testing Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global C-Reactive Protein Testing Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Thermo Fisher Scientific
• 7.2: F. Hoffmann-La Roche
• 7.3: Danaher
• 7.4: Quest Diagnostics
• 7.5: Siemens Healthineers
• 7.6: Abbott
• 7.7: Merck
• 7.8: Zoetis
• 7.9: Ortho Clinical Diagnostics
• 7.10: Getein Biotech